Back to CLDX

Eversept Partners, LP → CLDX

Eversept Partners, LP CLDX Position History

Celldex Therapeutics, Inc.

Quarters held
4
Latest value
$38.1M
Q3 2026
Peak value
$66.5M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$39M
Q1 2026$56.7M
Q2 2026$66.5M
Q3 2026$38.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$38.1M1.17M——
Q2 2026$66.5M1.79M——
Q1 2026$56.7M1.79M——
Q4 2025$39M1.43M——

Other funds holding CLDX

Other Eversept Partners, LP positions

UTHR

UNITED THERAPEUTICS CORP DEL

$176M
UTHR

UNITED THERAPEUTICS CORP DEL

$156.7M
UTHR

UNITED THERAPEUTICS CORP DEL

$155.9M
VERA

VERA THERAPEUTICS INC

$155.6M
EHC

ENCOMPASS HEALTH CORP

$131.5M
GLAXF

GSK PLC

$131.4M
ENSG

ENSIGN GROUP INC

$124.9M
UTHR

UNITED THERAPEUTICS CORP DEL

$123.1M